Clinical Trials Browser

Phase 2 × Carcinoma, Transitional Cell × Pemetrexed × Clear all

NCT05335941 2026-03-04

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

Phase 2 Active not recruiting

Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT02693717 2021-05-20

Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer

Phase 2 Terminated

7 enrolled 5 charts

Carcinoma, Transitional Cell

NCT01490437 2014-09-25

PECULIAR

Phase 2 Completed

Carcinoma, Transitional Cell